caseins and acetylcysteine
caseins has been researched along with acetylcysteine in 3 studies
Compound Research Comparison
Studies (caseins) | Trials (caseins) | Recent Studies (post-2010) (caseins) | Studies (acetylcysteine) | Trials (acetylcysteine) | Recent Studies (post-2010) (acetylcysteine) |
---|---|---|---|---|---|
16,863 | 561 | 4,170 | 14,580 | 1,046 | 5,960 |
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors
Authors | Studies |
---|---|
Anttila, A; Jusufovic, J; Kauppinen, H; Koivusalo, A; Lindahl, H; Rautelin, H; Rintala, R | 1 |
Chen, MC; Du, JY; Huang, CH; Lee, CF; Lee, YJ; Lin, TH; Shen, HJ; Wang, JH; Wu, YY | 1 |
Allen, MR; Avin, K; Chen, N; McNerney, E; Moe, S; Nyman, J; Wallace, J | 1 |
Trials
1 trial(s) available for caseins and acetylcysteine
Article | Year |
---|---|
Intraluminal casein model of necrotizing enterocolitis for assessment of mucosal destruction, bacterial translocation, and the effects of allopurinol and N-acetylcysteine.
Topics: Acetylcysteine; Allopurinol; Analysis of Variance; Animals; Animals, Newborn; Bacterial Translocation; Caseins; Disease Models, Animal; Enterocolitis, Necrotizing; Ileum; Intestinal Mucosa; Lymphatic System; Male; Swine | 2002 |
Other Studies
2 other study(ies) available for caseins and acetylcysteine
Article | Year |
---|---|
Suppression of prolactin signaling by pyrrolidine dithiocarbamate is alleviated by N-acetylcysteine in mammary epithelial cells.
Topics: Acetylcysteine; Animals; Caseins; Cattle; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation; Insulin; Insulin Receptor Substrate Proteins; JNK Mitogen-Activated Protein Kinases; Mammary Glands, Animal; Mice; NF-kappa B; Phosphorylation; Pregnancy; Prolactin; Pyrrolidines; Serine; Signal Transduction; Thiocarbamates | 2014 |
N-acetylcysteine (NAC), an anti-oxidant, does not improve bone mechanical properties in a rat model of progressive chronic kidney disease-mineral bone disorder.
Topics: Acetylcysteine; Animals; Antioxidants; Caseins; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Models, Animal; Disease Progression; Glycation End Products, Advanced; Humans; Kidney; Lipid Peroxidation; Male; Mutation; Nuclear Proteins; Oxidative Stress; Parathyroid Hormone; Rats; Tibia; X-Ray Microtomography | 2020 |